Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/adequacy-of-family-history-taking-in-ovarian-cancer-patients-a-mfQ6TIBWnW
References (26)
-
HJ Murff, D Byrne, S Syngal (2004)
Cancer risk assessment: quality and impact of the family history interviewAm J Prev Med, 27
-
A Finch, M Beiner, J Lubinski, HT Lynch, P Moller, B Rosen (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationJAMA, 296
-
SS Buys, E Partridge, A Black, CC Johnson, L Lamerato, C Isaacs (2011)
Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trialJAMA, 305
-
A Antoniou, PD Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesAm J Hum Genet, 72
-
MC King, JH Marks, JB Mandell (2003)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2Science, 302
-
A Ziogas, NK Horick, AY Kinney, JT Lowery, SM Domchek, C Isaacs (2011)
Clinically relevant changes in family history of cancer over timeJAMA, 306
-
SJ Ramus, SA Gayther (2009)
The contribution of BRCA1 and BRCA2 to ovarian cancerMol Oncol, 3
-
S Zhang, R Royer, S Li, JR McLaughlin, B Rosen, HA Risch (2011)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecol Oncol, 121
-
HJ Murff, DR Spigel, S Syngal (2004)
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer historyJAMA, 292
-
HA Risch, JR McLaughlin, DE Cole, B Rosen, L Bradley, E Kwan (2001)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancerAm J Hum Genet, 68
-
SC Rubin, MA Blackwood, C Bandera, K Behbakht, I Benjamin, TR Rebbeck (1998)
BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testingAm J Obstet Gynecol, 178
-
A Tutt, M Robson, JE Garber, SM Domchek, MW Audeh, JN Weitzel (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialLancet, 376
-
JF Stratton, P Pharoah, SK Smith, D Easton, BA Ponder (1998)
A systematic review and meta-analysis of family history and risk of ovarian cancerBr J Obstet Gynaecol, 105
-
FS Douglas, LC O’Dair, M Robinson, DG Evans, SA Lynch (1999)
The accuracy of diagnoses as reported in families with cancer: a retrospective studyJ Med Genet, 36
-
R Calderon-Margalit, O Paltiel (2004)
Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literatureInt J Cancer, 112
-
S Malander, M Ridderheim, A Masback, N Loman, U Kristoffersson, H Olsson (2004)
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern SwedenEur J Cancer, 40
-
A Ziogas, H Anton-Culver (2003)
Validation of family history data in cancer family registriesAm J Prev Med, 24
-
R Valdez, PW Yoon, N Qureshi, RF Green, MJ Khoury (2010)
Family history in public health practice: a genomic tool for disease prevention and health promotionAnnu Rev Public Health, 31
-
HT Lynch, MJ Casey, CL Snyder, C Bewtra, JF Lynch, M Butts (2009)
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and managementMol Oncol, 3
-
ND Kauff, JM Satagopan, ME Robson, L Scheuer, M Hensley, CA Hudis (2002)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutationN Engl J Med, 346
-
T Pal, J Permuth-Wey, JA Betts, JP Krischer, J Fiorica, H Arango (2005)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma casesCancer, 104
-
G Trano, HH Wasmuth, W Sjursen, E Hofsli, LJ Vatten (2009)
Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based studyColor Dis, 11
-
W Foo, JM Young, MJ Solomon, CM Wright (2009)
Family history? The forgotten question in high-risk colorectal cancer patientsColor Dis, 11
-
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van’t Veer, JE Garber (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsN Engl J Med, 346
-
ER Woodward, HV Sleightholme, AM Considine, S Williamson, JM McHugo, DG Cruger (2007)
Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffectiveBJOG, 114
-
DA Dijk, MJ Oostindier, WM Kloosterman-Boele, P Krijnen, HF Vasen (2007)
Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry dataFam Cancer, 6
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by The Author(s)
- Subject
- Biomedicine; Epidemiology; Biomedicine general; Human Genetics; Cancer Research
- ISSN
- 1389-9600
- eISSN
- 1573-7292
- DOI
- 10.1007/s10689-012-9518-6
- pmid
- 22388872
- Publisher site
- See Article on Publisher Site
Abstract
The aim of this study was to evaluate the adequacy of family history taking in epithelial ovarian cancer (EOC) patients and to identify factors that determine adequacy. Furthermore, the validity of family history taking was assessed by comparison with self-administered questionnaires. Medical records of all 1,112 EOC patients registered by the nation-wide cancer registry and diagnosed in eleven Dutch hospitals between 1996 and 2006 were reviewed. Adequate family history taking was defined as a written notification of the presence or absence of relatives with breast or ovarian cancer. Factors that were correlated with family history taking were identified using univariable and multivariable logistic regression. 147 patients filled in a postal questionnaire. An adequate family history was taken in 41% of all cases. Younger age, an academic hospital and having undergone surgery and/or chemotherapy were associated with adequate family history taking. The comparison with self-administered questionnaires showed a disagreement in 64% mainly due to missing data in medical records. Documentation on family history is either absent or inadequate in the medical records in the majority of EOC patients. These data urge for better uptake of hereditary cancer risk assessment. Different strategies for this assessment like improved family history taking and genetic testing in EOC patients should be explored.
Journal
Familial Cancer – Springer Journals
Published: Mar 3, 2012